Project Grant HT94252410200
Award Date 6/1/24
Completion Date 5/31/27
Dollars Obligated $882K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
- The U.S. Department of Defense's Defense Health Agency has awarded a $168,000 Project Grant titled "SENESCENCE-ASSOCIATED SOMATIC MUTATIONS IN LUNG CANCER ETIOLOGY" to the Albert Einstein College of Medicine, a private non-profit educational institution located in the Bronx, New York. The award, funded under the Military Medical Research and Development program (CFDA 12.420), will support basic, translational, and clinical research focused on improving the health and care of military...
- The Albert Einstein College of Medicine, a private non-profit educational institution in the Bronx, New York, has been awarded a $672,000 Project Grant by the Defense Health Agency, a component of the Department of Defense. The grant, which runs from March 1, 2024 to February 29, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420) and will support research on "Clonal Hematopoiesis as a Driver of Therapeutic Resistance and Metastatic Relapse in Breast...
- The U.S. Department of Defense's Defense Health Agency awarded a $672,000 Project Grant to the Albert Einstein College of Medicine in Bronx, NY to support the "MRNA TRANSLATION AND IMMUNE RECOGNITION IN MYC-DRIVEN LYMPHOMA" research project. This grant is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research initiatives to transform healthcare for military service members and the broader public. The 2-year project,...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $672,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2027. The award supports research investigating a novel synthetic lethal vulnerability in anaplastic thyroid cancer through inhibition of one-carbon metabolism. This two-year research initiative will be conducted at the institution's...
- Albert Einstein College of Medicine (AECOM) was awarded a $672,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on Treatment-Induced Metastasis in Ewing Sarcoma. The two-year grant runs from June 1, 2023 to May 31, 2025 and will support AECOM's investigation into medical solutions for metastatic cancers affecting service members, in line with the program's goals of transforming military...
- The Albert Einstein College of Medicine was awarded a $1,260,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support research into "A NOVEL IMMUNE CHECKPOINT PATHWAY IN HUMAN PROSTATE CANCER" from July 1, 2022 to June 30, 2025. The Military Medical Research and Development program aims to transform health care for service members and the public through innovative...
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $1.344 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2025, through April 30, 2029. The award supports research titled "Targeting Noncanonical Wnt Signaling to Prevent Ewing Sarcoma Metastases in a Novel Zebrafish Model," to be conducted at the institution's Bronx, New York location. This...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $3.29M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to support the production of cultured red blood cells for sickle cell disease patient support. The award, effective June 1, 2025 through May 31, 2029, represents a four-year research initiative focused on developing biomedical solutions relevant to military personnel and the broader public...
- The Department of the Army Medical Command awarded a $776,293 Project Grant to Albert Einstein College of Medicine to control the burden of metastatic disease in pancreatic ductal adenocarcinoma. The grant was awarded on September 15, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will run through September 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
- This $762,992 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the University of Texas MD Anderson Cancer Center to map and predict therapy resistance in small cell lung cancer (SCLC) using liquid biopsies. The 3-year award, effective July 1, 2024, will enable MD Anderson to conduct personalized analyses to better understand how SCLC tumors evolve and become resistant to treatment. This work aims to...